A Phase I/II Trial of VB-111 and Paclitaxel for Recurrent Platinum-Resistant Müllerian Cancer
Clinical trial NCT01711970 · COMPLETED
Trial details
- NCT number
- NCT01711970
- Sponsor
- Vascular Biogenics Ltd. operating as VBL Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2017-05-03
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.